Article
Diabetes therapy and cancer risk: Where do we stand when treating patients?
Several classes of diabetes drugs are under scrutiny for potentially promoting cancer in a population already at risk.
We do not suggest that these potential risks preclude the use of these agents in all patients, but rather that a discussion should occur between physician and patient. Diabetes therapy, as in treatment of other medical conditions, should be tailored to the individual patient, and all potential risk and benefits should be disclosed and considered.